1 Report Business Overview
    1.1 Study Scope
    1.2 Market Analysis by Type
        1.2.1 Global Artemisinin Combination Therapy Market Size Growth Rate by Type, 2017 VS 2021 VS 2028
        1.2.2 Artemether+Lumefantrine
        1.2.3 Artesunate+Amodiaquine
        1.2.4 Dihydroartemisinin+Piperaquine
        1.2.5 Artesunate+Mefloquine
        1.2.6 Artesunate+Sulfadoxine-Pyrimethamine
        1.2.7 Pyronaridine-Artesunate
        1.2.8 Other
    1.3 Market by Application
        1.3.1 Global Artemisinin Combination Therapy Market Size Growth Rate by Application, 2017 VS 2021 VS 2028
        1.3.2 Hospital
        1.3.3 Clinic
        1.3.4 Other
    1.4 Study Objectives
    1.5 Years Considered
2 Global Growth Trends
    2.1 Global Artemisinin Combination Therapy Market Perspective (2017-2028)
    2.2 Artemisinin Combination Therapy Growth Trends by Region
        2.2.1 Artemisinin Combination Therapy Market Size by Region: 2017 VS 2021 VS 2028
        2.2.2 Artemisinin Combination Therapy Historic Market Size by Region (2017-2022)
        2.2.3 Artemisinin Combination Therapy Forecasted Market Size by Region (2023-2028)
    2.3 Artemisinin Combination Therapy Market Dynamics
        2.3.1 Artemisinin Combination Therapy Industry Trends
        2.3.2 Artemisinin Combination Therapy Market Drivers
        2.3.3 Artemisinin Combination Therapy Market Challenges
        2.3.4 Artemisinin Combination Therapy Market Restraints
3 Competition Landscape by Key Players
    3.1 Global Top Artemisinin Combination Therapy Players by Revenue
        3.1.1 Global Top Artemisinin Combination Therapy Players by Revenue (2017-2022)
        3.1.2 Global Artemisinin Combination Therapy Revenue Market Share by Players (2017-2022)
    3.2 Global Artemisinin Combination Therapy Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
    3.3 Players Covered: Ranking by Artemisinin Combination Therapy Revenue
    3.4 Global Artemisinin Combination Therapy Market Concentration Ratio
        3.4.1 Global Artemisinin Combination Therapy Market Concentration Ratio (CR5 and HHI)
        3.4.2 Global Top 10 and Top 5 Companies by Artemisinin Combination Therapy Revenue in 2021
    3.5 Artemisinin Combination Therapy Key Players Head office and Area Served
    3.6 Key Players Artemisinin Combination Therapy Product Solution and Service
    3.7 Date of Enter into Artemisinin Combination Therapy Market
    3.8 Mergers & Acquisitions, Expansion Plans
4 Artemisinin Combination Therapy Breakdown Data by Type
    4.1 Global Artemisinin Combination Therapy Historic Market Size by Type (2017-2022)
    4.2 Global Artemisinin Combination Therapy Forecasted Market Size by Type (2023-2028)
5 Artemisinin Combination Therapy Breakdown Data by Application
    5.1 Global Artemisinin Combination Therapy Historic Market Size by Application (2017-2022)
    5.2 Global Artemisinin Combination Therapy Forecasted Market Size by Application (2023-2028)
6 North America
    6.1 North America Artemisinin Combination Therapy Market Size (2017-2028)
    6.2 North America Artemisinin Combination Therapy Market Size by Type
        6.2.1 North America Artemisinin Combination Therapy Market Size by Type (2017-2022)
        6.2.2 North America Artemisinin Combination Therapy Market Size by Type (2023-2028)
        6.2.3 North America Artemisinin Combination Therapy Market Share by Type (2017-2028)
    6.3 North America Artemisinin Combination Therapy Market Size by Application
        6.3.1 North America Artemisinin Combination Therapy Market Size by Application (2017-2022)
        6.3.2 North America Artemisinin Combination Therapy Market Size by Application (2023-2028)
        6.3.3 North America Artemisinin Combination Therapy Market Share by Application (2017-2028)
    6.4 North America Artemisinin Combination Therapy Market Size by Country
        6.4.1 North America Artemisinin Combination Therapy Market Size by Country (2017-2022)
        6.4.2 North America Artemisinin Combination Therapy Market Size by Country (2023-2028)
        6.4.3 U.S.
        6.4.4 Canada
7 Europe
    7.1 Europe Artemisinin Combination Therapy Market Size (2017-2028)
    7.2 Europe Artemisinin Combination Therapy Market Size by Type
        7.2.1 Europe Artemisinin Combination Therapy Market Size by Type (2017-2022)
        7.2.2 Europe Artemisinin Combination Therapy Market Size by Type (2023-2028)
        7.2.3 Europe Artemisinin Combination Therapy Market Share by Type (2017-2028)
    7.3 Europe Artemisinin Combination Therapy Market Size by Application
        7.3.1 Europe Artemisinin Combination Therapy Market Size by Application (2017-2022)
        7.3.2 Europe Artemisinin Combination Therapy Market Size by Application (2023-2028)
        7.3.3 Europe Artemisinin Combination Therapy Market Share by Application (2017-2028)
    7.4 Europe Artemisinin Combination Therapy Market Size by Country
        7.4.1 Europe Artemisinin Combination Therapy Market Size by Country (2017-2022)
        7.4.2 Europe Artemisinin Combination Therapy Market Size by Country (2023-2028)
        7.4.3 Germany
        7.4.4 France
        7.4.5 U.K.
        7.4.6 Italy
        7.4.7 Russia
        7.4.8 Nordic Countries
8 Asia-Pacific
    8.1 Asia-Pacific Artemisinin Combination Therapy Market Size (2017-2028)
    8.2 Asia-Pacific Artemisinin Combination Therapy Market Size by Type
        8.2.1 Asia-Pacific Artemisinin Combination Therapy Market Size by Type (2017-2022)
        8.2.2 Asia-Pacific Artemisinin Combination Therapy Market Size by Type (2023-2028)
        8.2.3 Asia-Pacific Artemisinin Combination Therapy Market Share by Type (2017-2028)
    8.3 Asia-Pacific Artemisinin Combination Therapy Market Size by Application
        8.3.1 Asia-Pacific Artemisinin Combination Therapy Market Size by Application (2017-2022)
        8.3.2 Asia-Pacific Artemisinin Combination Therapy Market Size by Application (2023-2028)
        8.3.3 Asia-Pacific Artemisinin Combination Therapy Market Share by Application (2017-2028)
    8.4 Asia-Pacific Artemisinin Combination Therapy Market Size by Region
        8.4.1 Asia-Pacific Artemisinin Combination Therapy Market Size by Region (2017-2022)
        8.4.2 Asia-Pacific Artemisinin Combination Therapy Market Size by Region (2023-2028)
        8.4.3 China
        8.4.4 Japan
        8.4.5 South Korea
        8.4.6 Southeast Asia
        8.4.7 India
        8.4.8 Australia 
9 Latin America
    9.1 Latin America Artemisinin Combination Therapy Market Size (2017-2028)
    9.2 Latin America Artemisinin Combination Therapy Market Size by Type
        9.2.1 Latin America Artemisinin Combination Therapy Market Size by Type (2017-2022)
        9.2.2 Latin America Artemisinin Combination Therapy Market Size by Type (2023-2028)
        9.2.3 Latin America Artemisinin Combination Therapy Market Share by Type (2017-2028)
    9.3 Latin America Artemisinin Combination Therapy Market Size by Application
        9.3.1 Latin America Artemisinin Combination Therapy Market Size by Application (2017-2022)
        9.3.2 Latin America Artemisinin Combination Therapy Market Size by Application (2023-2028)
        9.3.3 Latin America Artemisinin Combination Therapy Market Share by Application (2017-2028)
    9.4 Latin America Artemisinin Combination Therapy Market Size by Country
        9.4.1 Latin America Artemisinin Combination Therapy Market Size by Country (2017-2022)
        9.4.2 Latin America Artemisinin Combination Therapy Market Size by Country (2023-2028)
        9.4.3 Mexico
        9.4.4 Brazil
10 Middle East & Africa
    10.1 Middle East & Africa Artemisinin Combination Therapy Market Size (2017-2028)
    10.2 Middle East & Africa Artemisinin Combination Therapy Market Size by Type
        10.2.1 Middle East & Africa Artemisinin Combination Therapy Market Size by Type (2017-2022)
        10.2.2 Middle East & Africa Artemisinin Combination Therapy Market Size by Type (2023-2028)
        10.2.3 Middle East & Africa Artemisinin Combination Therapy Market Share by Type (2017-2028)
    10.3 Middle East & Africa Artemisinin Combination Therapy Market Size by Application
        10.3.1 Middle East & Africa Artemisinin Combination Therapy Market Size by Application (2017-2022)
        10.3.2 Middle East & Africa Artemisinin Combination Therapy Market Size by Application (2023-2028)
        10.3.3 Middle East & Africa Artemisinin Combination Therapy Market Share by Application (2017-2028)
    10.4 Middle East & Africa Artemisinin Combination Therapy Market Size by Country
        10.4.1 Middle East & Africa Artemisinin Combination Therapy Market Size by Country (2017-2022)
        10.4.2 Middle East & Africa Artemisinin Combination Therapy Market Size by Country (2023-2028)
        10.4.3 Turkey
        10.4.4 Saudi Arabia
        10.4.5 UAE
11 Key Players Profiles
    11.1 KPC Pharmaceuticals
        11.1.1 KPC Pharmaceuticals Company Details
        11.1.2 KPC Pharmaceuticals Business Overview
        11.1.3 KPC Pharmaceuticals Artemisinin Combination Therapy Introduction
        11.1.4 KPC Pharmaceuticals Revenue in Artemisinin Combination Therapy Business (2017-2022)
        11.1.5 KPC Pharmaceuticals Recent Developments
    11.2 Shanghai Fosun Pharmaceutical Industrial Development
        11.2.1 Shanghai Fosun Pharmaceutical Industrial Development Company Details
        11.2.2 Shanghai Fosun Pharmaceutical Industrial Development Business Overview
        11.2.3 Shanghai Fosun Pharmaceutical Industrial Development Artemisinin Combination Therapy Introduction
        11.2.4 Shanghai Fosun Pharmaceutical Industrial Development Revenue in Artemisinin Combination Therapy Business (2017-2022)
        11.2.5 Shanghai Fosun Pharmaceutical Industrial Development Recent Developments
    11.3 Sanofi
        11.3.1 Sanofi Company Details
        11.3.2 Sanofi Business Overview
        11.3.3 Sanofi Artemisinin Combination Therapy Introduction
        11.3.4 Sanofi Revenue in Artemisinin Combination Therapy Business (2017-2022)
        11.3.5 Sanofi Recent Developments
    11.4 Desano Holdings
        11.4.1 Desano Holdings Company Details
        11.4.2 Desano Holdings Business Overview
        11.4.3 Desano Holdings Artemisinin Combination Therapy Introduction
        11.4.4 Desano Holdings Revenue in Artemisinin Combination Therapy Business (2017-2022)
        11.4.5 Desano Holdings Recent Developments
    11.5 Calyx Chemicals and Pharmaceuticals
        11.5.1 Calyx Chemicals and Pharmaceuticals Company Details
        11.5.2 Calyx Chemicals and Pharmaceuticals Business Overview
        11.5.3 Calyx Chemicals and Pharmaceuticals Artemisinin Combination Therapy Introduction
        11.5.4 Calyx Chemicals and Pharmaceuticals Revenue in Artemisinin Combination Therapy Business (2017-2022)
        11.5.5 Calyx Chemicals and Pharmaceuticals Recent Developments
    11.6 Mylan
        11.6.1 Mylan Company Details
        11.6.2 Mylan Business Overview
        11.6.3 Mylan Artemisinin Combination Therapy Introduction
        11.6.4 Mylan Revenue in Artemisinin Combination Therapy Business (2017-2022)
        11.6.5 Mylan Recent Developments
    11.7 Novartis
        11.7.1 Novartis Company Details
        11.7.2 Novartis Business Overview
        11.7.3 Novartis Artemisinin Combination Therapy Introduction
        11.7.4 Novartis Revenue in Artemisinin Combination Therapy Business (2017-2022)
        11.7.5 Novartis Recent Developments
    11.8 Denk Pharma
        11.8.1 Denk Pharma Company Details
        11.8.2 Denk Pharma Business Overview
        11.8.3 Denk Pharma Artemisinin Combination Therapy Introduction
        11.8.4 Denk Pharma Revenue in Artemisinin Combination Therapy Business (2017-2022)
        11.8.5 Denk Pharma Recent Developments
    11.9 Hovid Berhad
        11.9.1 Hovid Berhad Company Details
        11.9.2 Hovid Berhad Business Overview
        11.9.3 Hovid Berhad Artemisinin Combination Therapy Introduction
        11.9.4 Hovid Berhad Revenue in Artemisinin Combination Therapy Business (2017-2022)
        11.9.5 Hovid Berhad Recent Developments
    11.10 Ipca Laboratories
        11.10.1 Ipca Laboratories Company Details
        11.10.2 Ipca Laboratories Business Overview
        11.10.3 Ipca Laboratories Artemisinin Combination Therapy Introduction
        11.10.4 Ipca Laboratories Revenue in Artemisinin Combination Therapy Business (2017-2022)
        11.10.5 Ipca Laboratories Recent Developments
    11.11 Cipla
        11.11.1 Cipla Company Details
        11.11.2 Cipla Business Overview
        11.11.3 Cipla Artemisinin Combination Therapy Introduction
        11.11.4 Cipla Revenue in Artemisinin Combination Therapy Business (2017-2022)
        11.11.5 Cipla Recent Developments
    11.12 Aspen Pharmacare Holdings
        11.12.1 Aspen Pharmacare Holdings Company Details
        11.12.2 Aspen Pharmacare Holdings Business Overview
        11.12.3 Aspen Pharmacare Holdings Artemisinin Combination Therapy Introduction
        11.12.4 Aspen Pharmacare Holdings Revenue in Artemisinin Combination Therapy Business (2017-2022)
        11.12.5 Aspen Pharmacare Holdings Recent Developments
    11.13 Ajanta Pharma
        11.13.1 Ajanta Pharma Company Details
        11.13.2 Ajanta Pharma Business Overview
        11.13.3 Ajanta Pharma Artemisinin Combination Therapy Introduction
        11.13.4 Ajanta Pharma Revenue in Artemisinin Combination Therapy Business (2017-2022)
        11.13.5 Ajanta Pharma Recent Developments
    11.14 Guilin Pharmaceuticals
        11.14.1 Guilin Pharmaceuticals Company Details
        11.14.2 Guilin Pharmaceuticals Business Overview
        11.14.3 Guilin Pharmaceuticals Artemisinin Combination Therapy Introduction
        11.14.4 Guilin Pharmaceuticals Revenue in Artemisinin Combination Therapy Business (2017-2022)
        11.14.5 Guilin Pharmaceuticals Recent Developments
12 Analyst's Viewpoints/Conclusions
13 Appendix
    13.1 Research Methodology
        13.1.1 Methodology/Research Approach
        13.1.2 Data Source
    13.2 Author Details
    13.3 Disclaimer
                  
              

                

                 
List of Tables
    Table 1. Global Artemisinin Combination Therapy Market Size Growth Rate by Type (US$ Million), 2017 VS 2021 VS 2028
    Table 2. Key Players of Artemether+Lumefantrine
    Table 3. Key Players of Artesunate+Amodiaquine
    Table 4. Key Players of Dihydroartemisinin+Piperaquine
    Table 5. Key Players of Artesunate+Mefloquine
    Table 6. Key Players of Artesunate+Sulfadoxine-Pyrimethamine
    Table 7. Key Players of Pyronaridine-Artesunate
    Table 8. Key Players of Other
    Table 9. Global Artemisinin Combination Therapy Market Size Growth Rate by Application (US$ Million), 2017 VS 2021 VS 2028
    Table 10. Global Artemisinin Combination Therapy Market Size by Region (US$ Million): 2017 VS 2021 VS 2028
    Table 11. Global Artemisinin Combination Therapy Market Size by Region (2017-2022) & (US$ Million)
    Table 12. Global Artemisinin Combination Therapy Market Share by Region (2017-2022)
    Table 13. Global Artemisinin Combination Therapy Forecasted Market Size by Region (2023-2028) & (US$ Million)
    Table 14. Global Artemisinin Combination Therapy Market Share by Region (2023-2028)
    Table 15. Artemisinin Combination Therapy Market Trends
    Table 16. Artemisinin Combination Therapy Market Drivers
    Table 17. Artemisinin Combination Therapy Market Challenges
    Table 18. Artemisinin Combination Therapy Market Restraints
    Table 19. Global Artemisinin Combination Therapy Revenue by Players (2017-2022) & (US$ Million)
    Table 20. Global Artemisinin Combination Therapy Revenue Share by Players (2017-2022)
    Table 21. Global Top Artemisinin Combination Therapy by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Artemisinin Combination Therapy as of 2021)
    Table 22. Ranking of Global Top Artemisinin Combination Therapy Companies by Revenue (US$ Million) in 2021
    Table 23. Global 5 Largest Players Market Share by Artemisinin Combination Therapy Revenue (CR5 and HHI) & (2017-2022)
    Table 24. Key Players Headquarters and Area Served
    Table 25. Key Players Artemisinin Combination Therapy Product Solution and Service
    Table 26. Date of Enter into Artemisinin Combination Therapy Market
    Table 27. Mergers & Acquisitions, Expansion Plans
    Table 28. Global Artemisinin Combination Therapy Market Size by Type (2017-2022) & (US$ Million)
    Table 29. Global Artemisinin Combination Therapy Revenue Market Share by Type (2017-2022)
    Table 30. Global Artemisinin Combination Therapy Forecasted Market Size by Type (2023-2028) & (US$ Million)
    Table 31. Global Artemisinin Combination Therapy Revenue Market Share by Type (2023-2028)
    Table 32. Global Artemisinin Combination Therapy Market Size by Application (2017-2022) & (US$ Million)
    Table 33. Global Artemisinin Combination Therapy Revenue Share by Application (2017-2022)
    Table 34. Global Artemisinin Combination Therapy Forecasted Market Size by Application (2023-2028) & (US$ Million)
    Table 35. Global Artemisinin Combination Therapy Revenue Share by Application (2023-2028)
    Table 36. North America Artemisinin Combination Therapy Market Size by Type (2017-2022) & (US$ Million)
    Table 37. North America Artemisinin Combination Therapy Market Size by Type (2023-2028) & (US$ Million)
    Table 38. North America Artemisinin Combination Therapy Market Size by Application (2017-2022) & (US$ Million)
    Table 39. North America Artemisinin Combination Therapy Market Size by Application (2023-2028) & (US$ Million)
    Table 40. North America Artemisinin Combination Therapy Market Size by Country (2017-2022) & (US$ Million)
    Table 41. North America Artemisinin Combination Therapy Market Size by Country (2023-2028) & (US$ Million)
    Table 42. Europe Artemisinin Combination Therapy Market Size by Type (2017-2022) & (US$ Million)
    Table 43. Europe Artemisinin Combination Therapy Market Size by Type (2023-2028) & (US$ Million)
    Table 44. Europe Artemisinin Combination Therapy Market Size by Application (2017-2022) & (US$ Million)
    Table 45. Europe Artemisinin Combination Therapy Market Size by Application (2023-2028) & (US$ Million)
    Table 46. Europe Artemisinin Combination Therapy Market Size by Country (2017-2022) & (US$ Million)
    Table 47. Europe Artemisinin Combination Therapy Market Size by Country (2023-2028) & (US$ Million)
    Table 48. Asia Pacific Artemisinin Combination Therapy Market Size by Type (2017-2022) & (US$ Million)
    Table 49. Asia Pacific Artemisinin Combination Therapy Market Size by Type (2023-2028) & (US$ Million)
    Table 50. Asia Pacific Artemisinin Combination Therapy Market Size by Application (2017-2022) & (US$ Million)
    Table 51. Asia Pacific Artemisinin Combination Therapy Market Size by Application (2023-2028) & (US$ Million)
    Table 52. Asia Pacific Artemisinin Combination Therapy Market Size by Region (2017-2022) & (US$ Million)
    Table 53. Asia Pacific Artemisinin Combination Therapy Market Size by Region (2023-2028) & (US$ Million)
    Table 54. Latin America Artemisinin Combination Therapy Market Size by Type (2017-2022) & (US$ Million)
    Table 55. Latin America Artemisinin Combination Therapy Market Size by Type (2023-2028) & (US$ Million)
    Table 56. Latin America Artemisinin Combination Therapy Market Size by Application (2017-2022) & (US$ Million)
    Table 57. Latin America Artemisinin Combination Therapy Market Size by Application (2023-2028) & (US$ Million)
    Table 58. Latin America Artemisinin Combination Therapy Market Size by Country (2017-2022) & (US$ Million)
    Table 59. Latin America Artemisinin Combination Therapy Market Size by Country (2023-2028) & (US$ Million)
    Table 60. Middle East and Africa Artemisinin Combination Therapy Market Size by Type (2017-2022) & (US$ Million)
    Table 61. Middle East and Africa Artemisinin Combination Therapy Market Size by Type (2023-2028) & (US$ Million)
    Table 62. Middle East and Africa Artemisinin Combination Therapy Market Size by Application (2017-2022) & (US$ Million)
    Table 63. Middle East and Africa Artemisinin Combination Therapy Market Size by Application (2023-2028) & (US$ Million)
    Table 64. Middle East and Africa Artemisinin Combination Therapy Market Size by Country (2017-2022) & (US$ Million)
    Table 65. Middle East and Africa Artemisinin Combination Therapy Market Size by Country (2023-2028) & (US$ Million)
    Table 66. KPC Pharmaceuticals Company Details
    Table 67. KPC Pharmaceuticals Business Overview
    Table 68. KPC Pharmaceuticals Artemisinin Combination Therapy Product
    Table 69. KPC Pharmaceuticals Revenue in Artemisinin Combination Therapy Business (2017-2022) & (US$ Million)
    Table 70. KPC Pharmaceuticals Recent Developments
    Table 71. Shanghai Fosun Pharmaceutical Industrial Development Company Details
    Table 72. Shanghai Fosun Pharmaceutical Industrial Development Business Overview
    Table 73. Shanghai Fosun Pharmaceutical Industrial Development Artemisinin Combination Therapy Product
    Table 74. Shanghai Fosun Pharmaceutical Industrial Development Revenue in Artemisinin Combination Therapy Business (2017-2022) & (US$ Million)
    Table 75. Shanghai Fosun Pharmaceutical Industrial Development Recent Developments
    Table 76. Sanofi Company Details
    Table 77. Sanofi Business Overview
    Table 78. Sanofi Artemisinin Combination Therapy Product
    Table 79. Sanofi Revenue in Artemisinin Combination Therapy Business (2017-2022) & (US$ Million)
    Table 80. Sanofi Recent Developments
    Table 81. Desano Holdings Company Details
    Table 82. Desano Holdings Business Overview
    Table 83. Desano Holdings Artemisinin Combination Therapy Product
    Table 84. Desano Holdings Revenue in Artemisinin Combination Therapy Business (2017-2022) & (US$ Million)
    Table 85. Desano Holdings Recent Developments
    Table 86. Calyx Chemicals and Pharmaceuticals Company Details
    Table 87. Calyx Chemicals and Pharmaceuticals Business Overview
    Table 88. Calyx Chemicals and Pharmaceuticals Artemisinin Combination Therapy Product
    Table 89. Calyx Chemicals and Pharmaceuticals Revenue in Artemisinin Combination Therapy Business (2017-2022) & (US$ Million)
    Table 90. Calyx Chemicals and Pharmaceuticals Recent Developments
    Table 91. Mylan Company Details
    Table 92. Mylan Business Overview
    Table 93. Mylan Artemisinin Combination Therapy Product
    Table 94. Mylan Revenue in Artemisinin Combination Therapy Business (2017-2022) & (US$ Million)
    Table 95. Mylan Recent Developments
    Table 96. Novartis Company Details
    Table 97. Novartis Business Overview
    Table 98. Novartis Artemisinin Combination Therapy Product
    Table 99. Novartis Revenue in Artemisinin Combination Therapy Business (2017-2022) & (US$ Million)
    Table 100. Novartis Recent Developments
    Table 101. Denk Pharma Company Details
    Table 102. Denk Pharma Business Overview
    Table 103. Denk Pharma Artemisinin Combination Therapy Product
    Table 104. Denk Pharma Revenue in Artemisinin Combination Therapy Business (2017-2022) & (US$ Million)
    Table 105. Denk Pharma Recent Developments
    Table 106. Hovid Berhad Company Details
    Table 107. Hovid Berhad Business Overview
    Table 108. Hovid Berhad Artemisinin Combination Therapy Product
    Table 109. Hovid Berhad Revenue in Artemisinin Combination Therapy Business (2017-2022) & (US$ Million)
    Table 110. Hovid Berhad Recent Developments
    Table 111. Ipca Laboratories Company Details
    Table 112. Ipca Laboratories Business Overview
    Table 113. Ipca Laboratories Artemisinin Combination Therapy Product
    Table 114. Ipca Laboratories Revenue in Artemisinin Combination Therapy Business (2017-2022) & (US$ Million)
    Table 115. Ipca Laboratories Recent Developments
    Table 116. Cipla Company Details
    Table 117. Cipla Business Overview
    Table 118. Cipla Artemisinin Combination Therapy Product
    Table 119. Cipla Revenue in Artemisinin Combination Therapy Business (2017-2022) & (US$ Million)
    Table 120. Cipla Recent Developments
    Table 121. Aspen Pharmacare Holdings Company Details
    Table 122. Aspen Pharmacare Holdings Business Overview
    Table 123. Aspen Pharmacare Holdings Artemisinin Combination Therapy Product
    Table 124. Aspen Pharmacare Holdings Revenue in Artemisinin Combination Therapy Business (2017-2022) & (US$ Million)
    Table 125. Aspen Pharmacare Holdings Recent Developments
    Table 126. Ajanta Pharma Company Details
    Table 127. Ajanta Pharma Business Overview
    Table 128. Ajanta Pharma Artemisinin Combination Therapy Product
    Table 129. Ajanta Pharma Revenue in Artemisinin Combination Therapy Business (2017-2022) & (US$ Million)
    Table 130. Ajanta Pharma Recent Developments
    Table 131. Guilin Pharmaceuticals Company Details
    Table 132. Guilin Pharmaceuticals Business Overview
    Table 133. Guilin Pharmaceuticals Artemisinin Combination Therapy Product
    Table 134. Guilin Pharmaceuticals Revenue in Artemisinin Combination Therapy Business (2017-2022) & (US$ Million)
    Table 135. Guilin Pharmaceuticals Recent Developments
    Table 136. Research Programs/Design for This Report
    Table 137. Key Data Information from Secondary Sources
    Table 138. Key Data Information from Primary Sources
List of Figures
    Figure 1. Global Artemisinin Combination Therapy Market Share by Type: 2021 VS 2028
    Figure 2. Artemether+Lumefantrine Features
    Figure 3. Artesunate+Amodiaquine Features
    Figure 4. Dihydroartemisinin+Piperaquine Features
    Figure 5. Artesunate+Mefloquine Features
    Figure 6. Artesunate+Sulfadoxine-Pyrimethamine Features
    Figure 7. Pyronaridine-Artesunate Features
    Figure 8. Other Features
    Figure 9. Global Artemisinin Combination Therapy Market Share by Application: 2021 VS 2028
    Figure 10. Hospital Case Studies
    Figure 11. Clinic Case Studies
    Figure 12. Other Case Studies
    Figure 13. Artemisinin Combination Therapy Report Years Considered
    Figure 14. Global Artemisinin Combination Therapy Market Size (US$ Million), Year-over-Year: 2017-2028
    Figure 15. Global Artemisinin Combination Therapy Market Size, (US$ Million), 2017 VS 2021 VS 2028
    Figure 16. Global Artemisinin Combination Therapy Market Share by Region: 2021 VS 2028
    Figure 17. Global Artemisinin Combination Therapy Market Share by Players in 2021
    Figure 18. Global Top Artemisinin Combination Therapy Players by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Artemisinin Combination Therapy as of 2021)
    Figure 19. The Top 10 and 5 Players Market Share by Artemisinin Combination Therapy Revenue in 2021
    Figure 20. North America Artemisinin Combination Therapy Market Size YoY (2017-2028) & (US$ Million)
    Figure 21. North America Artemisinin Combination Therapy Market Size Market Share by Type (2017-2028)
    Figure 22. North America Artemisinin Combination Therapy Market Size Market Share by Application (2017-2028)
    Figure 23. North America Artemisinin Combination Therapy Market Size Share by Country (2017-2028)
    Figure 24. United States Artemisinin Combination Therapy Market Size YoY Growth (2017-2028) & (US$ Million)
    Figure 25. Canada Artemisinin Combination Therapy Market Size YoY Growth (2017-2028) & (US$ Million)
    Figure 26. Europe Artemisinin Combination Therapy Market Size YoY (2017-2028) & (US$ Million)
    Figure 27. Europe Artemisinin Combination Therapy Market Size Market Share by Type (2017-2028)
    Figure 28. Europe Artemisinin Combination Therapy Market Size Market Share by Application (2017-2028)
    Figure 29. Europe Artemisinin Combination Therapy Market Size Share by Country (2017-2028)
    Figure 30. Germany Artemisinin Combination Therapy Market Size YoY Growth (2017-2028) & (US$ Million)
    Figure 31. France Artemisinin Combination Therapy Market Size YoY Growth (2017-2028) & (US$ Million)
    Figure 32. U.K. Artemisinin Combination Therapy Market Size YoY Growth (2017-2028) & (US$ Million)
    Figure 33. Italy Artemisinin Combination Therapy Market Size YoY Growth (2017-2028) & (US$ Million)
    Figure 34. Russia Artemisinin Combination Therapy Market Size YoY Growth (2017-2028) & (US$ Million)
    Figure 35. Nordic Countries Artemisinin Combination Therapy Market Size YoY Growth (2017-2028) & (US$ Million)
    Figure 36. Asia-Pacific Artemisinin Combination Therapy Market Size YoY (2017-2028) & (US$ Million)
    Figure 37. Asia Pacific Artemisinin Combination Therapy Market Size Market Share by Type (2017-2028)
    Figure 38. Asia Pacific Artemisinin Combination Therapy Market Size Market Share by Application (2017-2028)
    Figure 39. Asia Pacific Artemisinin Combination Therapy Market Size Share by Region (2017-2028)
    Figure 40. China Artemisinin Combination Therapy Market Size YoY Growth (2017-2028) & (US$ Million)
    Figure 41. Japan Artemisinin Combination Therapy Market Size YoY Growth (2017-2028) & (US$ Million)
    Figure 42. South Korea Artemisinin Combination Therapy Market Size YoY Growth (2017-2028) & (US$ Million)
    Figure 43. Southeast Asia Artemisinin Combination Therapy Market Size YoY Growth (2017-2028) & (US$ Million)
    Figure 44. India Artemisinin Combination Therapy Market Size YoY Growth (2017-2028) & (US$ Million)
    Figure 45. Australia Artemisinin Combination Therapy Market Size YoY Growth (2017-2028) & (US$ Million)
List of Figures
    Figure 46. Latin America Artemisinin Combination Therapy Market Size YoY (2017-2028) & (US$ Million)
    Figure 47. Latin America Artemisinin Combination Therapy Market Size Market Share by Type (2017-2028)
    Figure 48. Latin America Artemisinin Combination Therapy Market Size Market Share by Application (2017-2028)
    Figure 49. Latin America Artemisinin Combination Therapy Market Size Share by Country (2017-2028)
    Figure 50. Mexico Artemisinin Combination Therapy Market Size YoY Growth (2017-2028) & (US$ Million)
    Figure 51. Brazil Artemisinin Combination Therapy Market Size YoY Growth (2017-2028) & (US$ Million)
    Figure 52. Middle East & Africa Artemisinin Combination Therapy Market Size YoY (2017-2028) & (US$ Million)
    Figure 53. Middle East and Africa Artemisinin Combination Therapy Market Size Market Share by Type (2017-2028)
    Figure 54. Middle East and Africa Artemisinin Combination Therapy Market Size Market Share by Application (2017-2028)
    Figure 55. Middle East and Africa Artemisinin Combination Therapy Market Size Share by Country (2017-2028)
    Figure 56. Turkey Artemisinin Combination Therapy Market Size YoY Growth (2017-2028) & (US$ Million)
    Figure 57. Saudi Arabia Artemisinin Combination Therapy Market Size YoY Growth (2017-2028) & (US$ Million)
    Figure 58. UAE Artemisinin Combination Therapy Market Size YoY Growth (2017-2028) & (US$ Million)
    Figure 59. KPC Pharmaceuticals Revenue Growth Rate in Artemisinin Combination Therapy Business (2017-2022)
    Figure 60. Shanghai Fosun Pharmaceutical Industrial Development Revenue Growth Rate in Artemisinin Combination Therapy Business (2017-2022)
    Figure 61. Sanofi Revenue Growth Rate in Artemisinin Combination Therapy Business (2017-2022)
    Figure 62. Desano Holdings Revenue Growth Rate in Artemisinin Combination Therapy Business (2017-2022)
    Figure 63. Calyx Chemicals and Pharmaceuticals Revenue Growth Rate in Artemisinin Combination Therapy Business (2017-2022)
    Figure 64. Mylan Revenue Growth Rate in Artemisinin Combination Therapy Business (2017-2022)
    Figure 65. Novartis Revenue Growth Rate in Artemisinin Combination Therapy Business (2017-2022)
    Figure 66. Denk Pharma Revenue Growth Rate in Artemisinin Combination Therapy Business (2017-2022)
    Figure 67. Hovid Berhad Revenue Growth Rate in Artemisinin Combination Therapy Business (2017-2022)
    Figure 68. Ipca Laboratories Revenue Growth Rate in Artemisinin Combination Therapy Business (2017-2022)
    Figure 69. Cipla Revenue Growth Rate in Artemisinin Combination Therapy Business (2017-2022)
    Figure 70. Aspen Pharmacare Holdings Revenue Growth Rate in Artemisinin Combination Therapy Business (2017-2022)
    Figure 71. Ajanta Pharma Revenue Growth Rate in Artemisinin Combination Therapy Business (2017-2022)
    Figure 72. Guilin Pharmaceuticals Revenue Growth Rate in Artemisinin Combination Therapy Business (2017-2022)
    Figure 73. Bottom-up and Top-down Approaches for This Report
    Figure 74. Data Triangulation
    Figure 75. Key Executives Interviewed